S&P 500   4,320.06
DOW   33,963.84
QQQ   357.91
Enterprise Products: 7.33% Yield and 26-Years of Dividend Growth
66,000% upside on tiny biotech? (Ad)
A Tech Stock You've Never Heard Of Just Hit The Rally Button
Challenges Hit Broadcom Stock, But Analysts See EPS Growth
66,000% upside on tiny biotech? (Ad)
Is New IPO Instacart Already Hitting Speed Bumps?
Prospect Capital Corporation: A Gold Nugget or Value Trap?
66,000% upside on tiny biotech? (Ad)
Seagen, Activision Blizzard rise; Scholastic, Intel fall, Friday, 9/22/2023
52-week Low Names To Tip The Upside Scale In Your Favor
S&P 500   4,320.06
DOW   33,963.84
QQQ   357.91
Enterprise Products: 7.33% Yield and 26-Years of Dividend Growth
66,000% upside on tiny biotech? (Ad)
A Tech Stock You've Never Heard Of Just Hit The Rally Button
Challenges Hit Broadcom Stock, But Analysts See EPS Growth
66,000% upside on tiny biotech? (Ad)
Is New IPO Instacart Already Hitting Speed Bumps?
Prospect Capital Corporation: A Gold Nugget or Value Trap?
66,000% upside on tiny biotech? (Ad)
Seagen, Activision Blizzard rise; Scholastic, Intel fall, Friday, 9/22/2023
52-week Low Names To Tip The Upside Scale In Your Favor
S&P 500   4,320.06
DOW   33,963.84
QQQ   357.91
Enterprise Products: 7.33% Yield and 26-Years of Dividend Growth
66,000% upside on tiny biotech? (Ad)
A Tech Stock You've Never Heard Of Just Hit The Rally Button
Challenges Hit Broadcom Stock, But Analysts See EPS Growth
66,000% upside on tiny biotech? (Ad)
Is New IPO Instacart Already Hitting Speed Bumps?
Prospect Capital Corporation: A Gold Nugget or Value Trap?
66,000% upside on tiny biotech? (Ad)
Seagen, Activision Blizzard rise; Scholastic, Intel fall, Friday, 9/22/2023
52-week Low Names To Tip The Upside Scale In Your Favor
S&P 500   4,320.06
DOW   33,963.84
QQQ   357.91
Enterprise Products: 7.33% Yield and 26-Years of Dividend Growth
66,000% upside on tiny biotech? (Ad)
A Tech Stock You've Never Heard Of Just Hit The Rally Button
Challenges Hit Broadcom Stock, But Analysts See EPS Growth
66,000% upside on tiny biotech? (Ad)
Is New IPO Instacart Already Hitting Speed Bumps?
Prospect Capital Corporation: A Gold Nugget or Value Trap?
66,000% upside on tiny biotech? (Ad)
Seagen, Activision Blizzard rise; Scholastic, Intel fall, Friday, 9/22/2023
52-week Low Names To Tip The Upside Scale In Your Favor
NASDAQ:FWPAY

Forward Pharma A/S (FWPAY) Stock Forecast, Price & News

Notice: This company has been marked as potentially delisted and may not be actively trading.
Compare
Today's Range
$2.00
▼
$2.00
50-Day Range
$2.00
▼
$800.00
52-Week Range
$1.43
▼
$5.33
Volume
N/A
Average Volume
0 shs
Market Capitalization
$40,000.00
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
ProfileFinancialsHeadlinesSEC FilingsSocial Media

About Forward Pharma A/S

Forward Pharma A/S is a biopharmaceutical company, which engages in the research and development of medicinal treatment for inflammatory and neurological indications. It focuses on the immunomodulatory compound dimethyl fumarate and its derivatives. The company was founded by Florian Schönharting on July 2005 and is headquartered in Copenhagen, Denmark.


FWPAY Stock News Headlines

No headlines for this company have been tracked by MarketBeat.com
Receive FWPAY Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Forward Pharma A/S and its competitors with MarketBeat's FREE daily newsletter.

FWPAY Company Calendar

Today
9/23/2023
Fiscal Year End
12/31/2023
Get Stock Alerts

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Industry
Pharmaceutical preparations
Sub-Industry
N/A
Sector
Medical
Current Symbol
NASDAQ:FWPAY
CUSIP
N/A
CIK
1604924
Web
N/A
Phone
(453) 344-4242
Fax
N/A
Employees
N/A
Year Founded
N/A

Profitability

EPS (Most Recent Fiscal Year)
N/A
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
N/A
Net Margins
N/A
Pretax Margin
N/A
Return on Equity
N/A
Return on Assets
N/A

Debt

Debt-to-Equity Ratio
N/A
Current Ratio
N/A
Quick Ratio
N/A

Sales & Book Value

Annual Sales
N/A
Price / Sales
N/A
Cash Flow
N/A
Price / Cash Flow
N/A
Book Value
$2,882.00 per share
Price / Book
0.00

Miscellaneous

Outstanding Shares
20,000
Free Float
7,000
Market Cap
$40,000.00
Optionable
Not Optionable
Beta
1.31
13 Stocks Institutional Investors Won't Stop Buying Cover
13 Stocks Institutional Investors Won't Stop Buying

Which stocks are major institutional investors including hedge funds and endowments buying in today's market? Click the link below and we'll send you MarketBeat's list of thirteen stocks that institutional investors are buying up as quickly as they can.

Get This Free Report

Key Executives

  • Claus Bo Svendsen
    CEO & Principal Financial Officer
  • Thomas Carbone
    Principal Accounting Officer & VP-Finance

Key Competitors

View All Competitors













FWPAY Stock - Frequently Asked Questions

When did Forward Pharma A/S's stock split?

Forward Pharma A/S's stock reverse split before market open on Thursday, June 8th 2023. The 1-285.7139 reverse split was announced on Thursday, June 8th 2023. The number of shares owned by shareholders was adjusted after the market closes on Thursday, June 8th 2023. An investor that had 100 shares of stock prior to the reverse split would have 0 shares after the split.

What is Forward Pharma A/S's stock symbol?

Forward Pharma A/S trades on the NASDAQ under the ticker symbol "FWPAY."

What is Forward Pharma A/S's stock price today?

One share of FWPAY stock can currently be purchased for approximately $2.00.

How much money does Forward Pharma A/S make?

Forward Pharma A/S (NASDAQ:FWPAY) has a market capitalization of $40,000.00.

How can I contact Forward Pharma A/S?

Forward Pharma A/S's mailing address is Oestergade 24A, 1, Copenhagen K, Koebenhavn K 1100. The company can be reached via phone at (453) 344-4242 or via email at investors@forward-pharma.com.

This page (NASDAQ:FWPAY) was last updated on 9/23/2023 by MarketBeat.com Staff

My Account -